Abstract: A highly specific assay for plasma vitamin B.sub.12 levels in humans is disclosed. The assay employs intrinsic factor preparations obtained from mouse or rat stomachs, which intrinsic factors are free of R-protein and thus react specifically with vitamin B.sub.12 in a competitive binding assay. Detection of vitamin B.sub.12 levels is utilized in the diagnosis of several clinical disorders, such as pernicious anemia, a disease state which results in reduced circulating levels of vitamin B.sub.12 in the blood.
Type:
Grant
Filed:
May 21, 1980
Date of Patent:
October 19, 1982
Assignees:
Hoffmann-La Roche Inc., The Ideal Wilson Medical Center